Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
17 "Seung-Yong Jeong"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Benign bowel disease
Development of a home health care service platform for ostomy patient management
Seongwoo Yang, Ji Won Park, Hyuk Hur, Min Jung Kim, Seung-Yong Jeong, Kyounghoon Park, Ik Yong Kim
Ann Coloproctol. 2024;40(1):36-43.   Published online November 21, 2022
DOI: https://doi.org/10.3393/ac.2022.00360.0051
  • 4,055 View
  • 277 Download
  • 2 Web of Science
  • 1 Citations
AbstractAbstract PDF
Purpose
The use of an ostomy for urination and defecation leads to reduced quality of life. Although many ostomy management strategies are needed, such strategies are often implemented by patients. Thus, there is a need for a home health care service platform that can be used in ostomy patient management.
Methods
We developed an ostomy patient management platform by identifying the needs of patients and medical staff through the Chronic Care Ostomy Self-Management Training Program in the United States and from studies conducted in Korea.
Results
The platform encompassed physical management, psychological management, maintenance of social function, spiritual stability, and home medical care. These components were implemented through monitoring, self-care guidance, and a community platform. For the monitoring function, patients entered their health status in a mobile application (app); the medical staff at the affiliated hospital then monitored the stoma status through a web interface.
Conclusion
Our platform allows medical staff to monitor ostomy patients through a web interface and help such patients to fully manage their ostomy at home using an app. We expect that the continued development of patient-oriented functions in our app will allow ostomy patients to experience quality-of-life improvements.

Citations

Citations to this article as recorded by  
  • Lebensqualität von Stomapatienten
    Michael S. Kasparek
    coloproctology.2023; 45(4): 242.     CrossRef
Malignant disease, Rectal cancer,Prognosis
Initial local excision for clinical T1 rectal cancer showed comparable overall survival despite high local recurrence rate: a propensity-matched analysis
Jong Hee Hyun, Mohamed K. Alhanafy, Hyoung-Chul Park, Su Min Park, Sung-Chan Park, Dae Kyung Sohn, Duck-Woo Kim, Sung-Bum Kang, Seung-Yong Jeong, Kyu Joo Park, Jae Hwan Oh, on behalf of the Seoul Colorectal Research Group (SECOG)
Ann Coloproctol. 2022;38(2):166-175.   Published online October 6, 2021
DOI: https://doi.org/10.3393/ac.2021.00479.0068
  • 3,839 View
  • 162 Download
  • 10 Web of Science
  • 10 Citations
AbstractAbstract PDF
Purpose
Local excision (LE) is an alternative initial treatment for clinical T1 rectal cancer, and has avoided potential morbidity. This study aimed to evaluate the clinical outcomes of LE compared with total mesorectal excision (TME) for clinical T1 rectal cancer.
Methods
Between January 2000 and December 2011, we retrospectively reviewed from multicenter data in patients with clinically suspected T1 rectal cancer treated with either LE or TME. Of 1,071 patients, 106 were treated with LE and 965 were treated with TME. The data were analyzed using propensity score matching, with each group comprising 91 patients.
Results
After propensity score matching, the median follow-up time was 60.8 months (range, 0.6–150.6 months). After adjustment for the necessary variables, patients who underwent LE showed a significantly higher local recurrence rate than did those who underwent TME; however, there were no differences in disease-free survival and overall survival. In the multivariate analysis, age (hazard ratio [HR], 9.620; 95% confidence interval [CI], 3.415–27.098; P<0.001) and angiolymphatic invasion (HR, 3.63; 95% confidence interval, 1.33–9.89; P=0.012) were independently associated with overall survival. However, LE was neither associated with overall survival nor disease-free survival.
Conclusion
LE for clinical T1 rectal cancer yielded a higher local recurrence rate than did TME. Nevertheless, LE provided comparable overall survival rate and can be proposed as an optional treatment in terms of organ-preserving strategies.

Citations

Citations to this article as recorded by  
  • Performance reporting design in artificial intelligence studies using image-based TNM staging and prognostic parameters in rectal cancer: a systematic review
    Minsung Kim, Taeyong Park, Bo Young Oh, Min Jeong Kim, Bum-Joo Cho, Il Tae Son
    Annals of Coloproctology.2024; 40(1): 13.     CrossRef
  • Sex Disparities in Rectal Cancer Surgery: An In-Depth Analysis of Surgical Approaches and Outcomes
    Chungyeop Lee, In Ja Park
    The World Journal of Men's Health.2024; 42(2): 304.     CrossRef
  • Survival prognostic in different age groups of patients undergoing local versus radical excision for rectal cancer: a study based on the SEER database
    Jinghui Li, Liang Wen, Yongli Ma, Guosheng Zhang, Ping Wang, Chengzhi Huang, Xueqing Yao
    Updates in Surgery.2024; 76(3): 975.     CrossRef
  • Comparative analysis of organ preservation attempt and radical surgery in clinical T2N0 mid to low rectal cancer
    Hyeung-min Park, Jaram Lee, Soo Young Lee, Chang Hyun Kim, Hyeong Rok Kim
    International Journal of Colorectal Disease.2024;[Epub]     CrossRef
  • Organ preservation for early rectal cancer using preoperative chemoradiotherapy
    Gyung Mo Son
    Annals of Coloproctology.2023; 39(3): 191.     CrossRef
  • Surgical Techniques for Transanal Local Excision for Early Rectal Cancer
    Gyoung Tae Noh
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • How Can We Improve the Tumor Response to Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer?
    Jeonghee Han
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • Multidisciplinary treatment strategy for early rectal cancer
    Gyung Mo Son, In Young Lee, Sung Hwan Cho, Byung-Soo Park, Hyun Sung Kim, Su Bum Park, Hyung Wook Kim, Sang Bo Oh, Tae Un Kim, Dong Hoon Shin
    Precision and Future Medicine.2022; 6(1): 32.     CrossRef
  • The risk-benefit trade-off in local excision of early rectal cancer
    Chang Hyun Kim
    Annals of Coloproctology.2022; 38(2): 95.     CrossRef
  • Applications of propensity score matching: a case series of articles published in Annals of Coloproctology
    Hwa Jung Kim
    Annals of Coloproctology.2022; 38(6): 398.     CrossRef
Malignant disease, Rectal cancer, Functional outcomes
Validation of Korean Version of Low Anterior Resection Syndrome Score Questionnaire
Chang Woo Kim, Woon Kyung Jeong, Gyung Mo Son, Ik Yong Kim, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park, Suk-Hwan Lee
Ann Coloproctol. 2020;36(2):83-87.   Published online February 11, 2020
DOI: https://doi.org/10.3393/ac.2019.08.01
  • 4,940 View
  • 203 Download
  • 18 Web of Science
  • 17 Citations
AbstractAbstract PDF
Purpose
Patients who undergo radical surgery for rectal cancer often experience low anterior resection syndrome (LARS). Symptoms of this syndrome include frequent bowel movements, gas incontinence, fecal incontinence, fragmentation, and urgency. The aim of this study was to investigate the convergent validity, discriminative validity, and reliability of the Korean version of the LARS score questionnaire.
Methods
The English LARS score questionnaire was translated into Korean using the forward-and-back translation method. A total of 146 patients who underwent radical surgery for rectal cancer answered the Korean version of the LARS score questionnaire including an anchor question assessing the impact of bowel function. Participants answered the questionnaire once more after 2 weeks.
Results
The Korean LARS score questionnaire showed high convergent validity in terms of high correlation between the LARS score and quality of life (perfect fit 55.5% vs. moderate fit 37.6% vs. no fit 6.8%, respectively; P < 0.001). The LARS score also showed good discriminative validity between groups of patients differing by sex (29 for males vs. 25 for females; P = 0.014), tumor level (29 for ≤8 cm vs. 24 for >8 cm; P = 0.021), and radiotherapy (32 for yes vs. 24 for no; P = 0.001). The LARS score also demonstrated high reliability at test-retest with no difference between scores at the first and second tests (intraclass correlation coefficient: Q1 = 0.932; Q2 = 0.909, Q3 = 0.944, Q4 = 0.931, and Q5 = 0.942; P < 0.001, respectively).
Conclusion
The Korean version of the LARS score questionnaire has proven to be a valid and reliable tool for measuring LARS in Korean patients with rectal cancer.

Citations

Citations to this article as recorded by  
  • Bowel dysfunction and lower urinary tract symptoms on quality of life after sphincter-preserving surgery for rectal cancer: A cross-sectional study
    Hyekyung Kim, Hyedan Kim, Ok-Hee Cho
    European Journal of Oncology Nursing.2024; 69: 102524.     CrossRef
  • Effectiveness of personalized treatment stage-adjusted digital therapeutics in colorectal cancer: a randomized controlled trial
    Inah Kim, Ji Young Lim, Sun Woo Kim, Dong Wook Shin, Hee Cheol Kim, Yoon Ah Park, Yoon Suk Lee, Jung-Myun Kwak, Seok Ho Kang, Ji Youl Lee, Ji Hye Hwang
    BMC Cancer.2023;[Epub]     CrossRef
  • Low anterior resection syndrome
    Seung‐Bum Ryoo
    Annals of Gastroenterological Surgery.2023; 7(5): 719.     CrossRef
  • Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial
    Min Jung Kim, Dae Won Lee, Hyun-Cheol Kang, Ji Won Park, Seung-Bum Ryoo, Sae-Won Han, Kyung Su Kim, Eui Kyu Chie, Jae Hwan Oh, Woon Kyung Jeong, Byoung Hyuck Kim, Eun Mi Nam, Seung-Yong Jeong
    BMC Cancer.2023;[Epub]     CrossRef
  • Validation of low anterior resection syndrome score in Brazil with Portuguese
    Kelly C.L.R. Buzatti, Andy Petroianu, Søren Laurberg, Rodrigo G. Silva, Beatriz D.S. Rodrigues, Peter Christensen, Antonio Lacerda-Filho, Therese Juul
    Annals of Coloproctology.2023; 39(5): 402.     CrossRef
  • Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: a multicenter, randomized controlled trial (SOLAR trial)
    Min Kyu Kang, Soo Yeun Park, Jun Seok Park, Hye Jin Kim, Jong Gwang Kim, Byung Woog Kang, Jin Ho Baek, Seung Hyun Cho, An Na Seo, Duck-Woo Kim, Jin Kim, Se Jin Baek, Ji Hoon Kim, Ji Yeon Kim, Gi Won Ha, Eun Jung Park, In Ja Park, Chang Hyun Kim, Hyun Kang
    BMC Cancer.2023;[Epub]     CrossRef
  • Clinical Implication of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
    In Ja Park
    The Ewha Medical Journal.2022; 45(1): 3.     CrossRef
  • Low Anterior Resection Syndrome: Pathophysiology, Risk Factors, and Current Management
    Seung Mi Yeo, Gyung Mo Son
    The Ewha Medical Journal.2022;[Epub]     CrossRef
  • Validation of the Vietnamese version of the low anterior resection syndrome score questionnaire
    Tuong-Anh Mai-Phan, Vu Quang Pham
    Annals of Coloproctology.2022;[Epub]     CrossRef
  • Analgesic effect of structured anal skin care for perianal dermatitis after low anterior resection in the rectal cancer patients: prospective, single-center, open-label, therapeutic confirmatory, randomized clinical trial
    Gyung Mo Son, In Young Lee, Mi Sook Yun, Jung-Hea Youn, Hong Min An, Kyung Hee Kim, Seung Mi Yeo, Bokyung Ku, Myeong Suk Kwon, Kun Hyung Kim
    Annals of Surgical Treatment and Research.2022; 103(6): 360.     CrossRef
  • Two dominant patterns of low anterior resection syndrome and their effects on patients’ quality of life
    Min Jung Kim, Ji Won Park, Mi Ae Lee, Han-Ki Lim, Yoon-Hye Kwon, Seung-Bum Ryoo, Kyu Joo Park, Seung-Yong Jeong
    Scientific Reports.2021;[Epub]     CrossRef
  • Anterior resection syndrome: a randomized clinical trial of a 5-HT3 receptor antagonist (ramosetron) in male patients with rectal cancer
    S -B Ryoo, J W Park, D W Lee, M A Lee, Y -H Kwon, M J Kim, S H Moon, S -Y Jeong, K J Park
    British Journal of Surgery.2021; 108(6): 644.     CrossRef
  • The incidence and risk factors of low anterior resection syndrome (LARS) after sphincter-preserving surgery of rectal cancer: a systematic review and meta-analysis
    Rui Sun, Ziyi Dai, Yin Zhang, Junyang Lu, Yuelun Zhang, Yi Xiao
    Supportive Care in Cancer.2021; 29(12): 7249.     CrossRef
  • Defining low anterior resection syndrome (LARS): Scoring tools and patient-reported outcomes
    Dr Rebekka Troller, Dr Jeremy Meyer, Mr Justin Davies
    Seminars in Colon and Rectal Surgery.2021; 32(4): 100847.     CrossRef
  • The Effect of Anastomotic Leakage on the Incidence and Severity of Low Anterior Resection Syndrome in Patients Undergoing Proctectomy: A Propensity Score Matching Analysis
    Sungjin Kim, Sung Il Kang, So Hyun Kim, Jae-Hwang Kim
    Annals of Coloproctology.2021; 37(5): 281.     CrossRef
  • Robotic Intersphincteric Resection for Low Rectal Cancer: Technical Controversies and a Systematic Review on the Perioperative, Oncological, and Functional Outcomes
    Guglielmo Niccolò Piozzi, Seon Hahn Kim
    Annals of Coloproctology.2021; 37(6): 351.     CrossRef
  • Functional outcomes after sphincter-preserving surgeries for low-lying rectal cancer: A review
    Eun Jung Park, Seung Hyuk Baik
    Precision and Future Medicine.2021; 5(4): 164.     CrossRef
Oncologic Outcomes in Patients Who Undergo Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision for Locally Advanced Rectal Cancer: A 14-Year Experience in a Single Institution
Min Jung Kim, Seung-Yong Jeong, Ji Won Park, Seung-Bum Ryoo, Sang Sik Cho, Ki Young Lee, Kyu Joo Park
Ann Coloproctol. 2019;35(2):83-93.   Published online April 30, 2019
DOI: https://doi.org/10.3393/ac.2019.04.22.1
  • 4,309 View
  • 96 Download
  • 18 Web of Science
  • 16 Citations
AbstractAbstract PDF
Purpose
This study evaluated the oncologic outcomes of locally advanced rectal cancer patients who underwent preoperative neoadjuvant chemoradiotherapy (CRT) followed by surgery and determined the prognostic significance of pathologic complete response (pCR).
Methods
Between January 2002 and December 2015, 580 patients with rectal cancer who underwent surgery after neoadjuvant CRT were identified. Survival according to tumor response to CRT and pathologic stage was analyzed using the Kaplan-Meier method, and the Cox proportional hazard model was used to identify factors associated with survival outcomes.
Results
A total of 111 patients (23.7%) achieved pCR while the other 469 patients showed residual disease. Patients with pCR had a lower pretreatment carcinoembryonic antigen level and earlier cT classification than those with residual disease. With a median follow-up of 78 months, disease-free survival (DFS) and overall survival (OS) were significantly better in the pCR group than in the residual disease group. The 5-year DFS and 5-year OS for patients with ypStage 0, I, II, or III were 92.5%, 85.1%, 72.2%, 54.3% (P < 0.001) and 94.5%, 91.0%, 83.1%, 69.3%, respectively (P < 0.001). Pathologic AJCC stage after CRT was the most statistically significant independent predictor of OS (HR, 6.97 [95% confidence interval, 3.16–15.39] for stage III vs. stage 0) and DFS (HR, 7.30 [95% confidence interval, 3.63–14.67] for stage III vs. stage 0).
Conclusion
Rectal cancer patients who achieved pCR showed improved survival compared to those with residual disease after preoperative CRT. Moreover, pCR was an independent indicator of OS and DFS, and pathologic AJCC stage was correlated with survival after preoperative CRT.

Citations

Citations to this article as recorded by  
  • Predicting Positive Radial Margin on Restaging MRI of Patients with Low Rectal Cancer: Can We Do Better?
    Anurima Patra, Aisha Lakhani, Antony Augustine, Priyanka Mohapatra, Anu Eapen, Ashish Singh, Dipti Masih, Thomas S. Ram, Mark R. Jesudason, Rohin Mittal, Anuradha Chandramohan
    Indian Journal of Radiology and Imaging.2024; 34(01): 85.     CrossRef
  • A Review of Neoadjuvant Therapy and the Watch-and-Wait Protocol in Rectal Cancer: Current Evidence and Future Directions
    Iulian M Slavu, Octavian Munteanu, Florin Filipoiu, Raluca Tulin, Anca Monica Macovei Oprescu , Ileana Dima, Iulian A Dogaru, Adrian Tulin
    Cureus.2024;[Epub]     CrossRef
  • Clinical Implication of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
    In Ja Park
    The Ewha Medical Journal.2022; 45(1): 3.     CrossRef
  • Multidisciplinary treatment strategy for early rectal cancer
    Gyung Mo Son, In Young Lee, Sung Hwan Cho, Byung-Soo Park, Hyun Sung Kim, Su Bum Park, Hyung Wook Kim, Sang Bo Oh, Tae Un Kim, Dong Hoon Shin
    Precision and Future Medicine.2022; 6(1): 32.     CrossRef
  • Watch and wait strategies for rectal cancer: A systematic review
    In Ja Park
    Precision and Future Medicine.2022; 6(2): 91.     CrossRef
  • Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer
    Mohamedraed Elshami, Robert N. Goldstone, Lawrence S. Blaszkowsky, James C. Cusack, Theodore S. Hong, Jennifer Y. Wo, Motaz Qadan
    Diseases of the Colon & Rectum.2022; 65(10): 1224.     CrossRef
  • Neoadjuvant Radiotherapy Dose Escalation in Locally Advanced Rectal Cancer: a Systematic Review and Meta-analysis of Modern Treatment Approaches and Outcomes
    N. Hearn, D. Atwell, K. Cahill, J. Elks, D. Vignarajah, J. Lagopoulos, M. Min
    Clinical Oncology.2021; 33(1): e1.     CrossRef
  • Can normalized carcinoembryonic antigen following neoadjuvant chemoradiation predict tumour recurrence after curative resection for locally advanced rectal cancer?
    Youngki Hong, Amandeep Ghuman, Keat Seong Poh, Dimitri Krizzuk, Arun Nagarajan, Sudha Amarnath, Juan J. Nogueras, Steven D. Wexner, Giovanna DaSilva
    Colorectal Disease.2021; 23(6): 1346.     CrossRef
  • Omission of or Poor Response to Preoperative Chemoradiotherapy Impacts Radial Margin Positivity Rates in Locally Advanced Rectal Cancer
    Ana Sofia Ore, Gabrielle E. Dombek, Carlos A. Cordova-Cassia, Jeanne F. Quinn, Thomas E. Cataldo, Benjamin L. Schlechter, Matthew J. Abrams, Evangelos Messaris
    Diseases of the Colon & Rectum.2021; 64(6): 669.     CrossRef
  • Optimal Postoperative Surveillance Strategies for Colorectal Cancer: A Retrospective Observational Study
    Min-Young Park, In-Ja Park, Hyo-Seon Ryu, Jay Jung, Min-Sung Kim, Seok-Byung Lim, Chang-Sik Yu, Jin-Cheon Kim
    Cancers.2021; 13(14): 3502.     CrossRef
  • Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
    Ye Won Jeon, In Ja Park, Jeong Eun Kim, Jin-Hong Park, Seok-Byung Lim, Chan Wook Kim, Yong Sik Yoon, Jong Lyul Lee, Chang Sik Yu, Jin Cheon Kim
    World Journal of Gastrointestinal Surgery.2021; 13(9): 1000.     CrossRef
  • Comparison between Local Excision and Radical Resection for the Treatment of Rectal Cancer in ypT0-1 Patients: An Analysis of the Clinicopathological Factors and Survival Rates
    Soo Young Oh, In Ja Park, Young IL Kim, Jong-Lyul Lee, Chan Wook Kim, Yong Sik Yoon, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim
    Cancers.2021; 13(19): 4823.     CrossRef
  • Neoadjuvant radiotherapy dose escalation for locally advanced rectal cancers in the new era of radiotherapy: A review of literature
    Durim Delishaj, Ilaria Costanza Fumagalli, Stefano Ursino, Agostino Cristaudo, Francesco Colangelo, Antonio Stefanelli, Alessandro Alghisi, Giuseppe De Nobili, Romerai D’Amico, Alessandra Cocchi, Antonio Ardizzoia, Carlo Pietro Soatti
    World Journal of Clinical Cases.2021; 9(30): 9077.     CrossRef
  • Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: A Single-Center Experience and Literature Review
    Min Chul Kim, Jae Hwan Oh
    Annals of Coloproctology.2021; 37(6): 382.     CrossRef
  • Functional outcomes after sphincter-preserving surgeries for low-lying rectal cancer: A review
    Eun Jung Park, Seung Hyuk Baik
    Precision and Future Medicine.2021; 5(4): 164.     CrossRef
  • From Total Mesorectal Excision to Organ Preservation for the Treatment of Rectal Cancer
    Seong Kyu Baek
    Annals of Coloproctology.2019; 35(2): 51.     CrossRef
Case Report
Inflammatory Myofibroblastic Tumor of the Retroperitoneum Including Chronic Granulomatous Inflammation Suggesting Tuberculosis: A Case Report
Younglim Kim, Ji Won Park, Sungwhan Kim, Kil-Yong Lee, Jeongmo Bae, Yoon Kyung Jeon, Ji Min Im, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park
Ann Coloproctol. 2019;35(5):285-288.   Published online March 20, 2019
DOI: https://doi.org/10.3393/ac.2018.05.09
  • 4,031 View
  • 106 Download
AbstractAbstract PDF
An inflammatory myofibroblastic tumor (IMT) is a solid tumor of unknown etiology frequently affecting children and young adults and commonly affecting the lung or orbital region. We present a case involving a 41-year-old man who had an IMT combined with Mycobacterium tuberculosis infection in the retroperitoneum. He presented with only pain in the right lower abdomen without accompanying symptoms; a retroperitoneal mass was found on computed tomography. The tumor had invaded the end of the ileum and was attached to the omentum, so mass excision could not be performed. The tumor was completely excised surgically and had histological features diagnostic of an IMT. Histologic findings of the omentum were positive for Ziehl-Nielsen staining for acid-fast bacilli and for a positive polymerase chain reaction for M. tuberculosis. The patient had no apparent immune disorder. These findings made this case exceptional because IMTs, which are mostly due to atypical mycobacteria, have been found mainly in immunocompromised patients.
Original Article
Female Sex and Right-Sided Tumor Location Are Poor Prognostic Factors for Patients With Stage III Colon Cancer After a Curative Resection
Jung Ho Park, Hyoung-Chul Park, Sung Chan Park, Jae Hwan Oh, Duck-Woo Kim, Sung-Bum Kang, Seung Chul Heo, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park, for the Seoul Colorectal Group (SECOG)
Ann Coloproctol. 2018;34(6):286-291.   Published online December 31, 2018
DOI: https://doi.org/10.3393/ac.2018.10.29
  • 4,334 View
  • 117 Download
  • 1 Web of Science
  • 1 Citations
AbstractAbstract PDF
Purpose
Stage-IIIC colon cancer is an advanced disease; however, its oncologic outcomes and prognostic factors remain unclear. In this study, we aimed to determine the predictors of disease-free survival (DFS) in patients with stage-IIIC colon cancer.
Methods
From a multicenter database, we retrospectively enrolled 611 patients (355 men and 256 women) who had undergone a potentially curative resection for a stage-IIIC colon adenocarcinoma between 2003 and 2011. The primary end-point was the 5-year DFS.
Results
The median age was 62 years; 213 and 398 patients had right-sided colon cancer (RCC) and left-sided colon cancer (LCC), respectively. The 5-year DFS in all patients was 52.0%; median follow-up time was 35 months (range, 1–134 months). A multivariate Cox regression revealed that female sex (hazard ratio [HR], 1.50; 95% confidence interval [CI], 1.19–1.90; P < 0.01), right-sided tumor location (HR, 1.65; 95% CI, 1.29–2.11; P < 0.01), lymphatic invasion (HR, 1.52; 95% CI, 1.08–2.15; P < 0.01) and a high (≥0.4) metastatic lymph node ratio (HR, 3.72; 95% CI, 2.63–5.24; P < 0.01) were independent predictors of worse 5-year DFS. Female patients with RCC were 1.79 fold more likely to experience recurrence than male patients with LCC.
Conclusion
Female sex and right-sided tumor location are associated with higher tumor recurrence rates in patients with stage-IIIC colon cancers. Aggressive treatment and close surveillance should be planned for patients in these groups.

Citations

Citations to this article as recorded by  
  • Development and external validation of a nomogram predicting overall survival after curative resection of colon cancer
    Shuanhu Wang, Yakui Liu, Yi Shi, Jiajia Guan, Mulin Liu, Wenbin Wang
    Journal of International Medical Research.2021; 49(5): 030006052110150.     CrossRef
Erratum
Erratum: Biofeedback Therapy Before Ileostomy Closure in Patients Undergoing Sphincter-Saving Surgery for Rectal Cancer: A Pilot Study
Jeong-Ki Kim, Byeong Geon Jeon, Yoon Suk Song, Mi Sun Seo, Yoon-Hye Kwon, JI Won Park, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park
Ann Coloproctol. 2015;31(5):205-205.   Published online October 31, 2015
DOI: https://doi.org/10.3393/ac.2015.31.5.205
  • 3,322 View
  • 34 Download
PDF
Original Articles
Biofeedback Therapy Before Ileostomy Closure in Patients Undergoing Sphincter-Saving Surgery for Rectal Cancer: A Pilot Study
Jeong-Ki Kim, Byeong Geon Jeon, Yoon Suk Song, Mi Sun Seo, Yoon-Hye Kwon, JI Won Park, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park
Ann Coloproctol. 2015;31(4):138-143.   Published online August 31, 2015
DOI: https://doi.org/10.3393/ac.2015.31.4.138
  • 4,152 View
  • 65 Download
  • 12 Web of Science
  • 11 Citations
AbstractAbstract PDF
Purpose

This study prospectively investigated the effects of biofeedback therapy on objective anorectal function and subjective bowel function in patients after sphincter-saving surgery for rectal cancer.

Methods

Sixteen patients who underwent an ileostomy were randomized into two groups, one receiving conservative management with the Kegel maneuver and the other receiving active biofeedback before ileostomy closure. Among them, 12 patients (mean age, 57.5 years; range, 38 to 69 years; 6 patients in each group) completed the study. Conservative management included lifestyle modifications, Kegel exercises, and medication. Patients were evaluated at baseline and at 1, 3, 6, and 12 months after ileostomy closure by using anal manometry, modified Wexner Incontinence Scores (WISs), and fecal incontinence quality of life (FI-QoL) scores.

Results

Before the ileostomy closure, the groups did not differ in baseline clinical characteristics or resting manometric parameters. After 12 months of follow-up, the biofeedback group demonstrated a statistically significant improvement in the mean maximum squeezing pressure (from 146.3 to 178.9, P = 0.002). However, no beneficial effect on the WIS was noted for biofeedback compared to conservative management alone. Overall, the FI-QoL scores were increased significantly in both groups after ileostomy closure (P = 0.006), but did not differ significantly between the two groups.

Conclusion

Although the biofeedback therapy group demonstrated a statistically significant improvement in the maximum squeezing pressure, significant improvements in the WISs and the FI-QoL scores over time were noted in both groups. The study was terminated early because no therapeutic benefit of biofeedback had been demonstrated.

Citations

Citations to this article as recorded by  
  • The effectiveness of physiotherapy interventions on fecal incontinence and quality of life following colorectal surgery: a systematic review and meta-analysis of randomized controlled trials
    Ming Yan Pun, Pak Ho Leung, Tsz Ching Chan, Chunn Pang, Kin Hei Chan, Priya Kannan
    Supportive Care in Cancer.2024;[Epub]     CrossRef
  • Effectiveness of Pelvic Floor Muscle Training for Patients Following Low Anterior Resection
    Young Man Kim, Eui Geum Oh
    Journal of Wound, Ostomy & Continence Nursing.2023; 50(2): 142.     CrossRef
  • ILEOSTIM trial: a study protocol to evaluate the effectiveness of efferent loop stimulation before ileostomy reversal
    N. Blanco, I. Oliva, P. Tejedor, E. Pastor, A. Alvarellos, C. Pastor, J. Baixauli, J. Arredondo
    Techniques in Coloproctology.2023; 27(12): 1251.     CrossRef
  • Low anterior resection syndrome
    Seung‐Bum Ryoo
    Annals of Gastroenterological Surgery.2023; 7(5): 719.     CrossRef
  • Efficacy of Pelvic Floor Muscle Training for Postoperative Patients With Rectal Cancer: A Systematic Review and Meta-Analysis
    Yuki Nakashima, Kenichi Fudeyasu, Yuki Kataoka, Shunsuke Taito, Takashi Ariie, Yukio Mikami
    Cureus.2023;[Epub]     CrossRef
  • „Low anterior resection syndrome“ – Ursachen und therapeutische Ansätze
    Sigmar Stelzner, Juliane Kupsch, Sören Torge Mees
    Der Chirurg.2021; 92(7): 612.     CrossRef
  • Anterior resection syndrome: a randomized clinical trial of a 5-HT3 receptor antagonist (ramosetron) in male patients with rectal cancer
    S -B Ryoo, J W Park, D W Lee, M A Lee, Y -H Kwon, M J Kim, S H Moon, S -Y Jeong, K J Park
    British Journal of Surgery.2021; 108(6): 644.     CrossRef
  • Investigating Risk Factors for Complications after Ileostomy Reversal in Low Anterior Rectal Resection Patients: An Observational Study
    Mateusz Rubinkiewicz, Jan Witowski, Michał Wysocki, Magdalena Pisarska, Stanisław Kłęk, Andrzej Budzyński, Michał Pędziwiatr
    Journal of Clinical Medicine.2019; 8(10): 1567.     CrossRef
  • Mind–Body Interventions for Irritable Bowel Syndrome Patients in the Chinese Population: a Systematic Review and Meta-Analysis
    Weidong Wang, Fang Wang, Feng Fan, Ana Cristina Sedas, Jian Wang
    International Journal of Behavioral Medicine.2017; 24(2): 191.     CrossRef
  • Lentivirus‐mediated shRNA interference of ghrelin receptor blocks proliferation in the colorectal cancer cells
    An Liu, Chenggang Huang, Jia Xu, Xuehong Cai
    Cancer Medicine.2016; 5(9): 2417.     CrossRef
  • Biofeedback Therapy After Sphincter-Preservation Surgery for the Treatment of Rectal Cancer
    Ik Yong Kim
    Annals of Coloproctology.2015; 31(4): 119.     CrossRef
Knowledge of and Practice Patterns for Hereditary Colorectal Cancer Syndromes in Korean Surgical Residents
Jangho Park, Soo Young Lee, Duck-Woo Kim, Sung-Bum Kang, Seung-Yong Jeong, Kyu Joo Park
Ann Coloproctol. 2013;29(5):186-191.   Published online October 31, 2013
DOI: https://doi.org/10.3393/ac.2013.29.5.186
  • 3,742 View
  • 36 Download
  • 2 Citations
AbstractAbstract PDF
Purpose

Obtaining a detailed family history through detailed pedigree is essential in recognizing hereditary colorectal cancer (CRC) syndromes. This study was performed to assess the current knowledge and practice patterns of surgery residents regarding familial risk of CRC.

Methods

A questionnaire survey was performed to evaluate the knowledge and the level of recognition for analyses of family histories and hereditary CRC syndromes in 62 residents of the Department of Surgery, Seoul National University Hospital. The questionnaire consisted of 22 questions regarding practice patterns for, knowledge of, and resident education about hereditary CRC syndromes.

Results

Two-thirds of the residents answered that family history should be investigated at the first interview, but only 37% of them actually obtained pedigree detailed family history at the very beginning in actual clinical practice. Three-quarters of the residents answered that the quality of family history they obtained was poor. Most of them could diagnose hereditary nonpolyposis colorectal cancer and recommend an appropriate colonoscopy surveillance schedule; however, only 19% knew that cancer surveillance guidelines differed according to the family history. Most of our residents lacked knowledge of cancer genetics, such as causative genes, and diagnostic methods, including microsatellite instability test, and indicated a desire and need for more education regarding hereditary cancer and genetic testing during residency.

Conclusion

This study demonstrated that surgical residents' knowledge of hereditary cancer was not sufficient and that the quality of the family histories obtained in current practice has to be improved. More information regarding hereditary cancer should be considered in education programs for surgery residents.

Citations

Citations to this article as recorded by  
  • Efficacy, functional outcome and post‑operative complications of total abdominal colectomy with ileorectal anastomosis vs. segmental colectomy in hereditary non‑polyposis colorectal cancer
    Jie Sun, Mingjie Dong, Xiaoping Xiao
    Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
  • Clinicopathological Features and Type of Surgery for Lynch Syndrome: Changes during the Past Two Decades
    Il Tae Son, Duck-Woo Kim, Seung-Yong Jeong, Young-Kyoung Shin, Myong Hoon Ihn, Heung-Kwon Oh, Sung-Bum Kang, Kyu Joo Park, Jae Hwan Oh, Ja-Lok Ku, Jae-Gahb Park
    Cancer Research and Treatment.2016; 48(2): 605.     CrossRef
Characteristics and Survival of Korean Anal Cancer From the Korea Central Cancer Registry Data
Hyoung-Chul Park, Kyu-Won Jung, Byung-Woo Kim, Aesun Shin, Young-Joo Won, Jae Hwan Oh, Seung-Yong Jeong, Chang Sik Yu, Bong Hwa Lee
Ann Coloproctol. 2013;29(5):182-185.   Published online October 31, 2013
DOI: https://doi.org/10.3393/ac.2013.29.5.182
  • 5,989 View
  • 39 Download
  • 9 Citations
AbstractAbstract PDF
Purpose

In Korea, anal cancer is rare disease entity with specific clinical characteristics. Therefore, no survival analysis with a sufficient patient population has been performed. The aim of this study was to evaluate the characteristics of Korean anal cancer, focusing on the survival according to tumor histologies, sex, and a specific age group, using the nationwide cancer registry.

Methods

Using the Korea Central Cancer Registry, we analyzed a total of 2,552 cases from 1993 to 2010. We assessed the 5-year relative survival by using tumor histology. In addition, survival differences of Surveillance Epidemiology and End Results (SEER) stage were analyzed for both sexes and for young-age cancer (younger than 40 years) and advanced-age cancer (older than 70 years).

Results

The 5-year relative survival among anal cancer patients increased from 38.9% for the period 1993-1995 to 65.6% for the period 2006-2010. The anal squamous cell carcinoma was the most common histology and showed better survival than other types of cancer. Females demonstrated better survival than males in all SEER stages. The 5-year survivals for patients in whom anal cancer developed before the age of 40 and at or after the age of 40 were 62.4% and 51.6%, respectively. The 5-year survival for patients in whom cancer developed at or after the age of 70 was much worse than that for patients in whom the cancer had developed prior to that age.

Conclusion

Korean anal cancer has certain distinctive characteristics of survival according to tumor histology, sex, and age. Despite limitations on available data, this study used the nationwide database to provide important information on the survival of Korean patients with anal cancer.

Citations

Citations to this article as recorded by  
  • Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017–2021)
    Byung-Wook Eun, Enas Bahar, Stebin Xavier, Hyungwoo Kim, Dorota Borys
    Human Vaccines & Immunotherapeutics.2023;[Epub]     CrossRef
  • Long-term Oncologic Outcome and Its Relevant Factors in Anal Cancer in Korea: A Nationwide Data Analysis
    Hyuk Hur, Kyu-Won Jung, Byung-Woo Kim, Chang-Mo Oh, Young-Joo Won, Jae Hwan Oh, Nam Kyu Kim
    Annals of Coloproctology.2020; 36(1): 35.     CrossRef
  • Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea
    Young-Tak Kim, Beatriz Serrano, Jae-Kwan Lee, Hyunju Lee, Shin-Wha Lee, Crystal Freeman, Jin-Kyoung Oh, Laia Alemany, Francesc-Xavier Bosch, Laia Bruni
    Papillomavirus Research.2019; 7: 26.     CrossRef
  • Oncologic outcomes of squamous cell carcinoma of the anal canal after chemoradiation therapy
    Dae Ro Lim, Hyuk Hur, Byung Soh Min, Seung Hyuk Baik, Kang Young Lee, Nam Kyu Kim
    Korean Journal of Clinical Oncology.2016; 12(1): 41.     CrossRef
  • Trends and Analysis of Cancer Incidence for Common Male and Female Cancers in the Population of Punjab Province of Pakistan during 1984 to 2014
    Khalid Masood, Andleeb Masood, Junaid Zafar, Abubaker Shahid, Mujahid Kamran, Sohail Murad, Misbah Masood, Zafar Alluddin, Masooma Riaz, Naseem Akhter, Munir Ahmad, Fayyaz Ahmad, Javaid Akhtar, Muhammad Naeem
    Asian Pacific Journal of Cancer Prevention.2015; 16(13): 5297.     CrossRef
  • Reply on "Characteristics and Survival of Korean Anal Cancer From the Korea Central Cancer Registry Data"
    Hyoung-Chul Park, Bong Hwa Lee
    Annals of Coloproctology.2014; 30(1): 56.     CrossRef
  • Patterns and Trends with Cancer Incidence and Mortality Rates Reported by the China National Cancer Registry
    Peng-Lai Chen, Ting Zhao, Rui Feng, Jing Chai, Gui-Xian Tong, De-Bin Wang
    Asian Pacific Journal of Cancer Prevention.2014; 15(15): 6327.     CrossRef
  • Commentary on "Characteristics and Survival of Korean Anal Cancer From the Korea Central Cancer Registry Data"
    Mohammad Mohammadianpanah
    Annals of Coloproctology.2014; 30(1): 54.     CrossRef
  • Anal Cancer Study Based on Korea Central Cancer Registry Data: One Step Forward in Clinical Research
    Nam Kyu Kim
    Annals of Coloproctology.2013; 29(5): 177.     CrossRef
Data on the Characteristics and the Survival of Korean Patients With Colorectal Cancer From the Korea Central Cancer Registry
Hyoung-Chul Park, Aesun Shin, Byung-Woo Kim, Kyu-Won Jung, Young-Joo Won, Jae Hwan Oh, Seung-Yong Jeong, Chang Sik Yu, Bong Hwa Lee
Ann Coloproctol. 2013;29(4):144-149.   Published online August 29, 2013
DOI: https://doi.org/10.3393/ac.2013.29.4.144
  • 4,414 View
  • 51 Download
  • 34 Citations
AbstractAbstract PDF
Purpose

The incidence rates of colorectal cancer (CRC) in Korea have been increasing during the past decade. Therefore, it is important to understand the characteristics, including survival, of Korean CRC patients. The aim of this study was to use the nationwide cancer registry to evaluate the characteristics of Korean CRC, focusing on the survival, according to tumor location, sex, and specific age groups.

Methods

Using the Korea Central Cancer Registry (KCCR), we analyzed a total of 226,352 CRC cases diagnosed from 1993 to 2010. The five-year relative survivals were compared for the proximal colon, the distal colon, and the rectum. Survival rates were compared between men and women and between patients of young age (less than 40 years old) and patients of advanced age (70 years old or older).

Results

The 5-year survival rates were improved in all subsites between 1993 and 2010. Distal colon cancer showed favorable survival compared to proximal colon or rectal cancer. Females demonstrated worse survival for local or regional cancers, and this difference was significant in for patients in their seventies. Young patients (<40 years old) showed better survival rates for overall and proximal colon cancer comparable to those for older patients (≥40 years old), but advanced age patients (≥70 years old) had worse survivals for all tumor subsites compared to their younger counterparts (<70 years old). These trends were similar in distant CRC.

Conclusion

Korean CRC has certain distinct characteristics of survival according to tumor location, sex, and age. Despite the limitations of available data, this study contributes to a better understanding of survival differences in Korean CRC.

Citations

Citations to this article as recorded by  
  • Gender-specific aspects of oncological diseases: focus on stomach cancer and colorectal cancer
    Ilgiz G. Gataullin, Rishat M. Dinov, Bulat I. Gataullin, Yana А. Erpert
    Science and Innovations in Medicine.2024; 9(2): 138.     CrossRef
  • Neuroendocrine Carcinoma of the Rectum as a Cause of Acute Obstructive Abdomen. Case Report and Literature Review
    Marcos Lenin Zambrano Avellán, Rolando Alberto Castro Cardenas, Yerlyn Narcisa Villacis Hidalgo , Stefhany Tatiana Guerrero Saltos, María Lorena Armijos Pazmiño, María José Peña Pibaque, Flavio Hernan Ante Guanotuña, Josseline Sofía Solano Zambrano, P
    Salud, Ciencia y Tecnología.2024; 4: 975.     CrossRef
  • Age-related differences in colon and rectal cancer survival by stage, histology, and tumour site: An analysis of United States SEER-18 data
    Sophie Pilleron, Diana R. Withrow, Brian D. Nicholson, Eva J.A. Morris
    Cancer Epidemiology.2023; 84: 102363.     CrossRef
  • Sex and gender perspectives in colorectal cancer
    I. Baraibar, J. Ros, N. Saoudi, F. Salvà, A. García, M.R. Castells, J. Tabernero, E. Élez
    ESMO Open.2023; 8(2): 101204.     CrossRef
  • Sex‐specific differences in colorectal cancer: A multicenter retrospective cohort study
    Hyun Jin Joo, Hyun Seok Lee, Byung Ik Jang, Dae Bum Kim, Jae Hyun Kim, Jae Jun Park, Hyun Gun Kim, Il Hyun Baek, Jun Lee, Bun Kim
    Cancer Reports.2023;[Epub]     CrossRef
  • Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities?
    Silvia De Francia, Paola Berchialla, Tiziana Armando, Silvana Storto, Sarah Allegra, Veronica Sciannameo, Giulia Soave, Andrea Elio Sprio, Silvia Racca, Maria Rosaria Caiaffa, Libero Ciuffreda, Maria Valentina Mussa
    European Journal of Clinical Pharmacology.2022; 78(6): 1029.     CrossRef
  • Metformin, Statin Use, and Female Colorectal Cancer: A Population-Based Cohort Study in Taiwan
    Shu-Hua Hsu, De-Kai Syu, Yu-Chiao Wang, Chih-Kuang Liu, Ming-Chih Chen
    Journal of Clinical Medicine.2022; 11(15): 4469.     CrossRef
  • Clinicopathological Characteristics and Outcome of Adolescent and Young Adult-Onset Microsatellite Stable Colorectal Cancer Patients
    Kanjana Sukhokanjanachusak, Ananya Pongpaibul, Akarin Nimmannit, Charuwan Akewanlop, Krittiya Korphaisarn
    Journal of Adolescent and Young Adult Oncology.2021; 10(5): 573.     CrossRef
  • Patterns of age disparities in colon and lung cancer survival: a systematic narrative literature review
    Sophie Pilleron, Helen Gower, Maryska Janssen-Heijnen, Virginia Claire Signal, Jason K Gurney, Eva JA Morris, Ruth Cunningham, Diana Sarfati
    BMJ Open.2021; 11(3): e044239.     CrossRef
  • Clinicopathological patterns and survival outcomes of colorectal cancer among young adults in Malaysia: an institutional cohort study
    SW Wong, DY Ling, RQ Yeow, RW Chong, R Aziz, NA Aziz, KS Poh, AC Roslani
    Singapore Medical Journal.2021; 62(12): 636.     CrossRef
  • Laparoscopic approach for left-sided T4 colon cancer is a safe and feasible procedure, compared to open surgery
    Jung Ho Park, Hyoung-Chul Park, Sung Chan Park, Dae Kyung Sohn, Jae Hwan Oh, Sung-Bum Kang, Seung Chul Heo, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park
    Surgical Endoscopy.2019; 33(9): 2843.     CrossRef
  • Cross-national analysis about the difference of histopathological management in Tis and T1 colorectal cancer between Japan and Korea
    Naohisa Yoshida, Yuji Naito, Yutaka Inada, Yoshito Itoh, Sang Pyo Lee, Jeong Hwan Kim, In-Kyung Sung, Hyung Seok Park, Hye Seung Han, Masayoshi Nakanishi, Mitsuo Kishimoto, Sun-Young Lee
    Journal of the Anus, Rectum and Colon.2019; 3(1): 18.     CrossRef
  • Socioeconomic and demographic inequalities in stage at diagnosis and survival among colorectal cancer patients: evidence from a Swiss population‐based study
    Anita Feller, Kurt Schmidlin, Andrea Bordoni, Christine Bouchardy, Jean‐Luc Bulliard, Bertrand Camey, Isabelle Konzelmann, Manuela Maspoli, Miriam Wanner, Marcel Zwahlen, Kerri M. Clough‐Gorr
    Cancer Medicine.2018; 7(4): 1498.     CrossRef
  • Early onset sporadic colorectal cancer: Worrisome trends and oncogenic features
    Giulia Martina Cavestro, Alessandro Mannucci, Raffaella Alessia Zuppardo, Milena Di Leo, Elena Stoffel, Giovanni Tonon
    Digestive and Liver Disease.2018; 50(6): 521.     CrossRef
  • Updates on Cancer Epidemiology in Korea, 2018
    Sun-Seog Kweon
    Chonnam Medical Journal.2018; 54(2): 90.     CrossRef
  • Characteristics and Survival of Korean Patients With Colorectal Cancer Based on Data From the Korea Central Cancer Registry Data
    Hyuk Hur, Chang-Mo Oh, Young-Joo Won, Jae Hwan Oh, Nam Kyu Kim
    Annals of Coloproctology.2018; 34(4): 212.     CrossRef
  • Female Sex and Right-Sided Tumor Location Are Poor Prognostic Factors for Patients With Stage III Colon Cancer After a Curative Resection
    Jung Ho Park, Hyoung-Chul Park, Sung Chan Park, Jae Hwan Oh, Duck-Woo Kim, Sung-Bum Kang, Seung Chul Heo, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park
    Annals of Coloproctology.2018; 34(6): 286.     CrossRef
  • Comparison of 627 patients with right‐ and left‐sided colon cancer in China: Differences in clinicopathology, recurrence, and survival
    Qiong Qin, Lin Yang, Yong‐Kun Sun, Jian‐Ming Ying, Yan Song, Wen Zhang, Jin‐Wan Wang, Ai‐Ping Zhou
    Chronic Diseases and Translational Medicine.2017; 3(1): 51.     CrossRef
  • Treatment of radiation-induced cystitis and vulvodynia via a ganglion impar block using a lateral approach under computed tomography guidance: a case report
    Jeong-Eun Lee, Kyung-Hwa Kwak, Seong Wook Hong, Hoon Jung, Seung-Yeon Chung, Jun-Mo Park
    Korean Journal of Anesthesiology.2017; 70(1): 81.     CrossRef
  • Mitochondrial UQCRB as a new molecular prognostic biomarker of human colorectal cancer
    Hyun-Chul Kim, Junghwa Chang, Hannah S Lee, Ho Jeong Kwon
    Experimental & Molecular Medicine.2017; 49(11): e391.     CrossRef
  • Characteristics and outcomes of endoscopically resected colorectal cancers that arose from sessile serrated adenomas and traditional serrated adenomas
    Ji Yeon Seo, Seung Ho Choi, Jaeyoung Chun, Changhyun Lee, Ji Min Choi, Eun Hyo Jin, Sung Wook Hwang, Jong Pil Im, Sang Gyun Kim, Joo Sung Kim
    Intestinal Research.2016; 14(3): 270.     CrossRef
  • Surgical outcomes of Korean ulcerative colitis patients with and without colitis-associated cancer
    Yong Sik Yoon
    World Journal of Gastroenterology.2015; 21(12): 3547.     CrossRef
  • Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial
    Shapour Omidvari, Shadi Zohourinia, Mansour Ansari, Leila Ghahramani, Mohammad Zare-Bandamiri, Ahmad Mosalaei, Niloofar Ahmadloo, Saeedeh Pourahmad, Hamid Nasrolahi, Sayed Hasan Hamedi, Mohammad Mohammadianpanah
    Annals of Coloproctology.2015; 31(4): 123.     CrossRef
  • Clinical Features and Prognosis of Resectable Primary Colorectal Signet-Ring Cell Carcinoma
    Ho-Su Lee, Jae Seung Soh, Seohyun Lee, Jung Ho Bae, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sun A Kim, Young Soo Park, Seok-Byung Lim, Jin Cheon Kim, Chang Sik Yu, Dong-Hoon Yang
    Intestinal Research.2015; 13(4): 332.     CrossRef
  • Temporal Epidemiological Assessment of Colorectal Cancer Incidence and Mortality in East Kazakhstan, 2004-2013
    Kuantkan Zhabagin, Nurbek Igissinov, Zukhra Manambayeva, Tasbolat Adylkhanov, Marat Sandybayev, Murat Nurgazin, Adilzhan Massadykov, Sayat Tanatarov, Daniyar Aldyngurov, Nailya Urazalina, Aizhan Abiltayeva, Ainoor Baissalbayeva, Almagul Zhabagina, Dinara
    Asian Pacific Journal of Cancer Prevention.2015; 16(15): 6413.     CrossRef
  • The effect of high glucose levels on the hypermethylation of protein phosphatase 1 regulatory subunit 3C (PPP1R3C) gene in colorectal cancer
    SOO KYUNG LEE, JI WOOK MOON, YONG WOO LEE, JUNG OK LEE, SU JIN KIM, NAMI KIM, JIN KIM, HYEON SOO KIM, SUN-HWA PARK
    Journal of Genetics.2015; 94(1): 75.     CrossRef
  • Complete Resection of Colorectal Adenomas: What Are the Important Factors in Fellow Training?
    Ji Min Choi, Changhyun Lee, Jeong Hwan Park, Hyeon Jeong Oh, Sung Wook Hwang, Jaeyoung Chun, Seong-Joon Koh, Jong Pil Im, Ji Won Kim, Joo Sung Kim, Byeong Gwan Kim, Kook Lae Lee
    Digestive Diseases and Sciences.2015; 60(6): 1579.     CrossRef
  • Sex- and gender-specific disparities in colorectal cancer risk
    Sung-Eun Kim
    World Journal of Gastroenterology.2015; 21(17): 5167.     CrossRef
  • Colonoscopy Quality is the Answer for the Emerging Issue of Interval Cancer
    Jae Myung Cha
    Intestinal Research.2014; 12(2): 110.     CrossRef
  • Gender-specific Colorectal Cancer: Epidemiologic Difference and Role of Estrogen
    Hee Man Kim, Hyun-Soo Kim
    The Korean Journal of Gastroenterology.2014; 63(4): 201.     CrossRef
  • Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database
    H.‐Y. Yhim, M.‐J. Jang, S.‐M. Bang, K.H. Kim, Y.‐K. Kim, S.‐H. Nam, S.H. Bae, S.‐H. Kim, Y.‐C. Mun, I. Kim, C.W. Jung, D. Oh
    Journal of Thrombosis and Haemostasis.2014; 12(7): 1035.     CrossRef
  • Reply on "Data on the Characteristics and the Survival of Korean Patients With Colorectal Cancer From the Korea Central Cancer Registry"
    Hyoung-Chul Park, Bong Hwa Lee
    Annals of Coloproctology.2014; 30(3): 153.     CrossRef
  • Commentary on "Data on the Characteristics and the Survival of Korean Patients With Colorectal Cancer From the Korea Central Cancer Registry"
    Mohammad Mohammadianpanah
    Annals of Coloproctology.2014; 30(3): 151.     CrossRef
  • What Should Be Done to Increase Survival in Patients With Colorectal Cancer?
    Min Ro Lee, Jong Hun Kim
    Annals of Coloproctology.2013; 29(4): 135.     CrossRef
Case Report
Rectal Perforation Caused by Anal Stricture After Hemorrhoid Treatment
Yong Joon Suh, Heon-Kyun Ha, Heung-Kwon Oh, Rumi Shin, Seung-Yong Jeong, Kyu Joo Park
Ann Coloproctol. 2013;29(1):28-30.   Published online February 28, 2013
DOI: https://doi.org/10.3393/ac.2013.29.1.28
  • 3,939 View
  • 38 Download
  • 1 Citations
AbstractAbstract PDF

Inappropriate therapies for hemorrhoids can lead to various complications including anorectal stricture. We report a patient presenting with catastrophic rectal perforation due to severe anal stricture after inappropriate hemorrhoid treatment. A 67-years old man with perianal pain visited the emergency room. The hemorrhoids accompanied by constipation, had tortured him since his youth. Thus he had undergone injection sclerotherapy several times by an unlicensed therapist and hemorrhoidectomy twice at the clinics of private practitioners. His body temperature was as high as 38.5℃. The computed tomographic scan showed a focal perforation of posterior rectal wall. The emergency operation was performed. The fibrotic tissues of the anal canal were excised. And then a sigmoid loop colostomy was constructed. The patient was discharged four days following the operation. This report calls attention to the enormous risk of unlicensed injection sclerotherapy and overzealous hemorrhoidectomy resulting in scarring, progressive stricture, and eventual rectal perforation.

Citations

Citations to this article as recorded by  
  • Laser hemorrhoidoplasty for hemorrhoidal disease: a systematic review and meta-analysis
    Hendry Lie, Evelyn Franca Caesarini, Antonius Agung Purnama, Andry Irawan, Taufik Sudirman, Wifanto Saditya Jeo, Bernardus Parish Budiono, Erik Prabowo, M. Iqbal Rivai, Ryanto Karobuana Sitepu
    Lasers in Medical Science.2022; 37(9): 3621.     CrossRef
Editorial
Single-Incision Laparoscopic Appendectomy
Seung-Yong Jeong
J Korean Soc Coloproctol. 2012;28(6):282-283.   Published online December 31, 2012
DOI: https://doi.org/10.3393/jksc.2012.28.6.282
  • 2,551 View
  • 42 Download
  • 2 Citations
PDF

Citations

Citations to this article as recorded by  
  • Single-port Laparoscopic Appendectomy: Beyond the Learning Curve: A Retrospective Comparison With Multi-port Laparoscopic Appendectomy
    Sarah Assali, Sarah Eapen, Terry Carman, Sophia Horattas, Christopher R. Daigle, Charudutt Paranjape
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2018; 28(5): 291.     CrossRef
  • Feasibility of Single Port Laparoscopic Surgery in Patients with Perforated Appendicitis
    Byung Seo Choi, Geon Young Byun, Seong Bae Hwang, Sung Ryul Lee
    The Journal of Minimally Invasive Surgery.2016; 19(1): 19.     CrossRef
Original Article
Does T3 Subdivision Correlate with Nodal or Distant Metastasis in Colorectal Cancer?
Hong Yeol Yoo, Rumi Shin, Heon-Kyun Ha, Heung-Kwon Oh, Seung-Yong Jeong, Kyu Joo Park, Gyeong Hoon Kang, Woo Ho Kim, Jae-Gahb Park
J Korean Soc Coloproctol. 2012;28(3):160-164.   Published online June 30, 2012
DOI: https://doi.org/10.3393/jksc.2012.28.3.160
  • 3,848 View
  • 32 Download
  • 10 Citations
AbstractAbstract PDF
Purpose

We analyzed the clinical data of T3 colorectal cancer patients to assess whether T3 subdivision correlates with node (N) or metastasis (M) staging and stage-independent factors.

Methods

Five hundred fifty-five patients who underwent surgery for primary colorectal cancer from January 2003 to December 2009 were analyzed for T3 subdivision. T3 subdivision was determined by the depth of invasion beyond the outer border of the proper muscle (T3a, <1 mm; T3b, 1 to 5 mm; T3c, >5 to 15 mm; T3d, >15 mm). We investigated the correlation between T3 subdivision and N, M staging and stage-independent prognostic factors including angiolymphatic invasion (ALI), venous invasion (VI) and perineural invasion (PNI).

Results

The tumors of the 555 patients were subclassified as T3a in 86 patients (15.5%), T3b in 209 patients (37.7%), T3c in 210 patients (37.8%) and T3d in 50 patients (9.0%). The nodal metastasis rates were 39.5% for T3a, 56.5% for T3b, 75.7% for T3c and 74.0% for T3d. The distant metastasis rates were 7.0% for T3a 9.1% for T3b, 27.1% for T3c and 40.0% for T3d. Both N and M staging correlated with T3 subdivision (Spearman's rho = 0.288, 0.276, respectively; P < 0.001). Other stage-independent prognostic factors correlated well with T3 subdivision (Spearman's rho = 0.250, P < 0.001 for ALI; rho = 0.146, P < 0.001 for VI; rho = 0.271, P < 0.001 for PNI).

Conclusion

Subdivision of T3 colorectal cancer correlates with nodal and metastasis staging. Moreover, it correlates with other prognostic factors for colorectal cancer.

Citations

Citations to this article as recorded by  
  • Facteurs pronostiques : degré d’invasion de la sous-séreuse, distance tumeur-séreuse et invasion de la limitante élastique de la sous-séreuse dans l’adénocarcinome colique
    Arnaud Ronfaut, Christophe Attencourt, Jean-Rene Tesson, Charles Sabbagh, Jean-Marc Regimbeau, Denis Chatelain
    Annales de Pathologie.2024;[Epub]     CrossRef
  • Do treated rectal tumors appear differently on MRI after chemotherapy versus chemoradiotherapy?
    Yu Shen, Yanqiong Wen, Liang Bi, Xuyang Yang, Xiaoling Gong, Xiangbing Deng, Wenjian Meng, Ziqiang Wang
    Abdominal Radiology.2023; 49(3): 774.     CrossRef
  • Pathology and Prognosis of Colonic Adenocarcinomas With Intermediate Primary Tumor Stage Between pT2 and pT3
    John D. Paulsen, Alexandros D. Polydorides
    Archives of Pathology & Laboratory Medicine.2022; 146(5): 591.     CrossRef
  • Prognostic significance of additional histologic features for subclassification of pathological T3 colon cancer
    Lorenzo Macchi, Quoc Riccardo Bao, Laura Albertoni, Matteo Fassan, Valentina Chiminazzo, Marco Scarpa, Gaya Spolverato, Salvatore Pucciarelli
    International Journal of Clinical Oncology.2022; 27(9): 1428.     CrossRef
  • The value of diffusion kurtosis imaging and intravoxel incoherent motion quantitative parameters in predicting synchronous distant metastasis of rectal cancer
    Xue Ding, Danqi Sun, Qiuchen Guo, Yeting Li, Hao Chen, Xiaoxiao Dai, Guohua Fan, Yongyou Wu, Guangqiang Chen, Yonggang Li
    BMC Cancer.2022;[Epub]     CrossRef
  • The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper
    Vincenzo Valentini, Corrie Marijnen, Geerard Beets, Krzysztof Bujko, Berardino De Bari, Andres Cervantes, Giuditta Chiloiro, Claudio Coco, Maria Antonietta Gambacorta, Robert Glynne-Jones, Karin Haustermans, Elisa Meldolesi, Femke Peters, Claus Rödel, Har
    Radiotherapy and Oncology.2020; 142: 6.     CrossRef
  • Whole-lesion Apparent Diffusion Coefficient First- and Second-Order Texture Features for the Characterization of Rectal Cancer Pathological Factors
    Weifeng Li, Zhuoran Jiang, Yue Guan, Ying Chen, Xiaolin Huang, Song Liu, Jian He, Zhengyang Zhou, Yun Ge
    Journal of Computer Assisted Tomography.2018; 42(4): 642.     CrossRef
  • A meta-analysis assessing the survival implications of subclassifying T3 rectal tumours
    M.R.S. Siddiqui, C. Simillis, J. Bhoday, N.J. Battersby, J. Mok, S. Rasheed, P. Tekkis, A.M. Abulafi, G. Brown
    European Journal of Cancer.2018; 104: 47.     CrossRef
  • Extramural extension as indicator for postoperative adjuvant chemotherapy in Stage IIA (pT3N0) colon cancer
    Yoshito Akagi, Kazuo Shirouzu, Tetsushi Kinugasa
    Journal of Surgical Oncology.2013; 108(6): 358.     CrossRef
  • T3 Subdivision Correlation with Nodal or Distant Metastasis in Colorectal Cancer; Is It Practically Useful?
    Nam Kyu Kim
    Journal of the Korean Society of Coloproctology.2012; 28(3): 119.     CrossRef
Editorial
Long-term Oncologic Outcomes of Laparoscopic Resection for Colorectal Cancer
Seung-Yong Jeong
J Korean Soc Coloproctol. 2011;27(2):53-53.   Published online April 30, 2011
DOI: https://doi.org/10.3393/jksc.2011.27.2.53
  • 2,673 View
  • 12 Download
PDF

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP